Delivery Order SPE2DB22D9112-SPE2DB24FE6XH

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XTANDI 40 MG CAPSULE 120S to the U.S. Department of Defense (DoD), specifically the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $101,771.28, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's...
This federal contract award is for the delivery of XTANDI 80 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $12,508.77 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,169.59 firm fixed-price delivery order is for the supply of XTANDI 40 MG TABLET 120S to support the medical needs of Department of Defense (DoD) healthcare facilities. The award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award, valued at $12,508.77, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's Medical Supply Chain program, with a firm fixed-price pricing type and an ultimate completion date of May 8, 2024. The contract is for the delivery of XTANDI 40 MG TABLET 120S, a pharmaceutical product, to support the recurring...
This federal contract award is for the delivery of XTANDI 80 MG TABLET 60S pharmaceutical products to the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract, valued at $4,169.59, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award is for the delivery of XTANDI 80 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $4,169.59 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of May 19, 2025 and was awarded on May 16, 2025. It is not associated with a set-aside program. DMS Pharmaceutical Group Inc. has a significant...
This federal contract award is for the delivery of XTANDI 40 MG CAPSULE 120S to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed price of $4,311.35 and a completion date of April 25, 2024. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $4,169.59, is for the supply of the prescription drug XTANDI 80 MG TABLET 60S. The contract is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,169.59 firm fixed-price delivery order is for the supply of XTANDI 40 MG TABLET 120S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $4,169.59, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm-fixed-price delivery order for the provision of XTANDI 40 MG TABLET 120S, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA under the...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB24FE6XH
    Delivery Order

This federal contract award is for the delivery of XTANDI 40 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $4,169.59, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.

The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the U.S. Armed Forces and their dependents.

Generated 12/4/24, 9:31 AM